Role of mass drug administration in elimination of Plasmodium falciparum malaria: a consensus modelling study

The Lancet Global Health

Volumn 5, Issue 7, 2017, Pages e680-e687

  Brady, Oliver J ^a   Slater, Hannah C ^b   Pemberton Ross, Peter ^c,d   Wenger, Edward ^e   Maude, Richard J ^f,g,h   Ghani, Azra C ^b   Penny, Melissa A ^c,d   Gerardin, Jaline ^e   White, Lisa J ^f,g   Chitnis, Nakul ^c,d   Aguas, Ricardo ^f,g   Hay, Simon I ^g,i   Smith, David L ⁱ   Stuckey, Erin M ^j   Okiro, Emelda A ^j,k   Smith, Thomas A ^c,d   Okell, Lucy C ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^d UNIVERSITY OF BASEL   (Switzerland)

^e INSTITUTE FOR DISEASE MODELING   (United States)

^f MAHIDOL UNIVERSITY   (Thailand)

^g UNIVERSITY OF OXFORD   (United Kingdom)

^h HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

ⁱ UNIVERSITY OF WASHINGTON   (United States)

^j BILL AND MELINDA GATES FOUNDATION   (United States)

^k KEMRI WELLCOME TRUST RESEARCH PROGRAMME   (Kenya)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

ARTICLE; CLINICAL EFFECTIVENESS; DISEASE CLEARANCE; DISEASE TRANSMISSION; DRUG ADMINISTRATION; HUMAN; INFECTION RATE; MALARIA FALCIPARUM; MATHEMATICAL MODEL; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; VECTOR CONTROL; CONSENSUS; ISOLATION AND PURIFICATION; MASS DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PROCEDURES; THEORETICAL MODEL; TRANSMISSION;

ANTIMALARIALS; ARTEMISININS; CONSENSUS; HUMANS; MALARIA, FALCIPARUM; MASS DRUG ADMINISTRATION; MODELS, THEORETICAL; PLASMODIUM FALCIPARUM; PREVALENCE;

EID: 85019743879     PISSN: None     EISSN: 2214109X     Source Type: Journal    
DOI: 10.1016/S2214-109X(17)30220-6     Document Type: Article

References (39)

1. Bhatt, S, Weiss, DJ, Cameron, E, et al. The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015. Nature 526 (2015), 207–211.
2. Newby, G, Hwang, J, Koita, K, et al. Review of mass drug administration for malaria and its operational challenges. Am J Trop Med Hyg 93 (2015), 125–134.
3. Poirot, E, Skarbinski, J, Sinclair, D, Kachur, SP, Slutsker, L, Hwang, J, Mass drug administration for malaria. Cochrane Database Syst Rev, 12, 2013 CD008846.
4. Von Seidlein, L, Dondorp, A, Fighting fire with fire: mass antimalarial drug administrations in an era of antimalarial resistance. Expert Rev Anti Infect Ther 13 (2015), 715–730.
5. Killeen, GF, Characterizing, controlling and eliminating residual malaria transmission. Malar J, 13, 2014, 330.
6. Global Malaria Programme. The role of mass drug administration, mass screening and treatment, and focal screening and treatment for malaria. http://www.who.int/malaria/publications/atoz/role-of-mda-for-malaria.pdf?ua=1 (accessed Jan 8, 2017).
7. WHO. Mass drug administration, mass screening and treatment and focal screening and treatment for malaria. http://www.who.int/malaria/mpac/mpac-sept2015-erg-mda-report.pdf?ua=1 (accessed Jan 8, 2017).
8. Smith, T, Ross, A, Maire, N, et al. Ensemble modeling of the likely public health impact of a pre-erythrocytic malaria vaccine. PLoS Med, 9, 2012, e1001157.
9. Gerardin, J, Bever, CA, Hamainza, B, Miller, JM, Eckhoff, PA, Wenger, EA, Optimal population-level infection detection strategies for malaria control and elimination in a spatial model of malaria transmission. PLoS Comput Biol, 12, 2016, e1004707.
10. Griffin, JT, Ferguson, NM, Ghani, AC, Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa. Nat Commun, 5, 2014, 3136.
11. Griffin, JT, Bhatt, S, Sinka, ME, et al. Potential for reduction of burden and local elimination of malaria by reducing Plasmodium falciparum malaria transmission: a mathematical modelling study. Lancet Infect Dis 16 (2016), 465–472.
12. Maude, RJ, Socheat, D, Nguon, C, et al. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. PLoS One, 7, 2012, e37166.
13. Maude, RJ, Nguon, C, Dondorp, AM, White, LJ, White, NJ, The diminishing returns of atovaquone-proguanil for elimination of Plasmodium falciparum malaria: modelling mass drug administration and treatment. Malar J, 13, 2014, 380.
14. Smith, T, Maire, N, Ross, A, et al. Towards a comprehensive simulation model of malaria epidemiology and control. Parasitology 135 (2008), 1507–1516.
15. Penny, MA, Verity, R, Bever, CA, et al. Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models. Lancet 387 (2016), 367–375.
16. Wenger, EA, Eckhoff, PA, A mathematical model of the impact of present and future malaria vaccines. Malar J, 12, 2013, 126.
17. Eckhoff, P, Mathematical models of within-host and transmission dynamics to determine effects of malaria interventions in a variety of transmission settings. Am J Trop Med Hyg 88 (2013), 817–827.
18. Maude, RJ, Socheat, D, Nguon, C, et al. Optimising strategies for Plasmodium falciparum malaria elimination in Cambodia: primaquine, mass drug administration and artemisinin resistance. PLoS One, 7, 2012, e37166.
19. Chitnis, N, Hardy, D, Smith, T, A periodically-forced mathematical model for the seasonal dynamics of malaria in mosquitoes. Bull Math Biol 74 (2012), 1098–1124.
20. Eckhoff, P, P falciparum infection durations and infectiousness are shaped by antigenic variation and innate and adaptive host immunity in a mathematical model. PLoS One, 7, 2012, e44950.
21. Maire, N, Smith, T, Ross, A, Owusu-Agyei, S, Dietz, K, Molineaux, L, A model for natural immunity to asexual blood stages of Plasmodium falciparum malaria in endemic areas. Am J Trop Med Hyg 75:suppl (2006), 19–31.
22. Gerardin, J, Eckhoff, P, Wenger, EA, Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination. BMC Infect Dis, 15, 2015, 144.
23. Nikolov, M, Bever, CA, Upfill-Brown, A, et al. Malaria elimination campaigns in the Lake Kariba region of Zambia: a spatial dynamical model. PLoS Comput Biol, 12, 2016, e1005192.
24. Escudie, A, Hamon, J, Schneider, J, Resultats d'une chimioprophylaxie antipaludique de masse par l'association amino-4-quinoleine/amino-8-quinoleine en milieu rural africain de la region de Bobo-Dioulasso (Haute Volta) 1960. Méd Trop 22 (1962), 268–290.
25. Song, J, Socheat, D, Tan, B, et al. Rapid and effective malaria control in Cambodia through mass administration of artemisinin-piperaquine. Malar J, 9, 2010, 57.
26. Smith, T, Maire, N, Dietz, K, et al. Relationship between the entomologic inoculation rate and the force of infection for Plasmodium falciparum malaria. Am J Trop Med Hyg 75:suppl (2006), 11–18.
27. Stuckey, EM, Miller, JM, Littrell, M, Chitnis, N, Steketee, R, Operational strategies of anti-malarial drug campaigns for malaria elimination in Zambia's southern province: a simulation study. Malar J, 15, 2016, 148.
28. Ross, A, Killeen, G, Smith, T, Relationships between host infectivity to mosquitoes and asexual parasite density in Plasmodium falciparum. Am J Trop Med Hyg 75:suppl (2006), 32–37.
29. Chabot-Couture, G, Nigmatulina, K, Eckhoff, P, An environmental data set for vector-borne disease modeling and epidemiology. PLoS One, 9, 2014, e94741.
30. Walker, PGT, Griffin, JT, Ferguson, NM, Ghani, AC, Estimating the most efficient allocation of interventions to achieve reductions in Plasmodium falciparum malaria burden and transmission in Africa: a modelling study. Lancet Glob Health 4 (2016), e474–e484.
31. Griffin, JT, The interaction between seasonality and pulsed interventions against malaria in their effects on the reproduction number. PLoS Comput Biol, 11, 2015, e1004057.
32. Okell, LC, Griffin, JT, Kleinschmidt, I, et al. The potential contribution of mass treatment to the control of Plasmodium falciparum malaria. PLoS One, 6, 2011, e20179.
33. Yukich, J, Chitnis, N, When can malaria control and elimination programmes safely reduce vector control efforts? A simulation study. http://www.who.int/malaria/mpac/sep2015/en/ (accessed Jan 8, 2017).
34. Crowell, V, Hardy, D, Briet, O, Chitnis, N, Maire, N, Smith, T, Can we depend on case management to prevent re-establishment of P falciparum malaria, after local interruption of transmission?. Epidemics 4 (2012), 1–8.
35. Eaton, JW, Johnson, LF, Salomon, JA, et al. HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med, 9, 2012, e1001245.
36. Stolk, WA, Walker, M, Coffeng, LE, Basanez, MG, de Vlas, SJ, Required duration of mass ivermectin treatment for onchocerciasis elimination in Africa: a comparative modelling analysis. Parasit Vectors, 8, 2015, 552.
37. Irvine, MA, Reimer, LJ, Njenga, SM, et al. Modelling strategies to break transmission of lymphatic filariasis—aggregation, adherence and vector competence greatly alter elimination. Parasit Vectors, 8, 2015, 547.
38. Kyelem, D, Biswas, G, Bockarie, MJ, et al. Determinants of success in national programs to eliminate lymphatic filariasis: a perspective identifying essential elements and research needs. Am J Trop Med Hyg 79 (2008), 480–484.
39. Kastner, RJ, Stone, CM, Steinmann, P, Tanner, M, Tediosi, F, What is needed to eradicate lymphatic filariasis? A model-based assessment on the impact of scaling up mass drug administration programs. PLoS Negl Trop Dis, 9, 2015, e0004147.